ClinicalTrials.gov
public full text
Public Domain
Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia
To evaluate the efficacy and safety of solifenacin succinate as add-on therapy for overactive bladder (OAB) symptoms in men who have been treated for benign prostatic hyperplasia (BPH) with tamsulosin hydrochloride for at least 6 weeks
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Solifenacin Plus Tadalafil vs Solifenacin Alone for Overactive Bladder in Females#890089
- Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder#993392
- Study of ONO-8577 in Patients With Overactive Bladder#838586
- Extended-Release Oxybutynin for the Treatment of Neurogenic Detrusor Overactivity#852045
- A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder#804496
Record · ID 1124987
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive